← Human Trials & Peer-Reviewed Studies

Improving Rates of Vitamin D Supplementation in Somali Immigrant Infants: A Prospective Interventional Pilot Trial.

Plain-language guide to PMID 35708579 (2022): pilot clinical trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
35708579
Journal
South Dakota medicine : the journal of the South Dakota State Medical Association
Year
2022
Study type
Clinical Trial
Authors
Cook JS et al. (4 authors)

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a clinical trial.

Rates of vitamin D deficiency and nutritional rickets have been rising over the past several decades, particularly in high-risk infants.

This pilot study assessed the impact of providing free vitamin D supplements, a culturally-appropriate educational brochure, and a brief counseling session about the importance of both vitamin D supplementation and breastfeeding to the parents of Somali infants at routine office visits from newborn through 6 months of age at three Federally Qualified Health Centers in Colorado.

The researchers also assessed the impact this intervention had on rates of breastfeeding.

Who Took Part

By PubMed's age tags, the people studied were infants, women only.

Twenty-five Somali infants aged 24 weeks or less were identified by searching electronic health records and enrolled into a historic control group.

The parents were then surveyed by phone regarding breastfeeding and vitamin D supplementation.

How the Study Was Run

The design is described as pilot.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

Subsequently, 37 families with newborn Somali infants were identified and enrolled into the intervention arm of the trial.

What Was Measured

Topics PubMed links to this paper include Breast Feeding, Dietary Supplements, Emigrants and Immigrants, Pilot Projects, Somalia and Vitamin D.

What This Means in Plain Language

The paper is a pilot study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2022 (South Dakota medicine : the journal of the South Dakota State Medical Association), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.